Lara Longpre - 10 May 2021 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Chief Development Officer
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 May 2021
Net transactions value
+$18,407
Form type
4
Filing time
12 May 2021, 17:38:59 UTC
Previous filing
18 Mar 2024
Next filing
01 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $18,407 +1,259 +1.7% $14.62 77,081 10 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 1,259 shares by the Reporting Person on May 10, 2021 pursuant to the Issuer's Employee Stock Purchase Plan.